Study record
Mitochondrial-derived microproteins in lung disease: insights and implications
Behan M, Yen K, Cohen P et al. · Am J Physiol Lung Cell Mol Physiol · 2026
What this study reported
Reviewed published work on mitochondrial-derived microproteins, noting that most of it concerns MOTS-c and humanin in high-mitochondrial-density tissues and in age-related disease rather than in the lung. Summarised reported mitochondrial, nuclear and extracellular actions of these peptides and how their levels have been reported to change across disease states. Identified gaps in the literature on acute lung injury, chronic obstructive pulmonary disease, allergic asthma and pulmonary fibrosis.
Limitations
Narrative review with no stated search strategy, largely a gap analysis because little primary pulmonary data on MOTS-c exists, and MOTS-c is discussed alongside other microproteins rather than appraised on its own.
Study record
| Study model | Review |
|---|---|
| Substance studied | SeveralMore than one of these is central to the paper (common for reviews). |
| Species | Not reported |
| System studied | Published literature on mitochondrial-derived microproteins in lung homeostasis and lung disease |
| Population | Not reported |
| Design | Narrative review |
| Sample size as reported | Not reported |
| Control group | Not reported |
| Route (data field only) | Not reported |
| Endpoints measured | reported mitochondrial, nuclear and extracellular actions of MDPs; MDP levels across disease states; knowledge gaps in acute lung injury, COPD, allergic asthma and pulmonary fibrosis |
| Pathways measured | Not reported |
| Research areas | Lung · Mitochondrial biology |
| Evidence tier | R — Review (context, not evidence) |
| Publication types | Journal Article, Review, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't |
Appraisal
Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.
- Relevance to MOTS-c
- Indirect
- Model applicability
- n/a
- Sample size
- n/a
- Controls
- n/a
- Outcome validity
- n/a
- Support for its own conclusion
- Weak
Provenance
- Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
- Annotated from the published abstract.
- Editorial review: approved (2026-11-11).
- Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.